Genetic determinants of bone mineral density loss in Aromatase inhibitors treatment

被引：0
|
作者：
Rodriguez-Sanz, Maria [1 ]
Prieto-alhambra, Daniel [2 ]
Servitja-Tormo, Sonia [3 ]
Torres-Del-Pliego, Elisa [4 ]
Mellibovsky, Leonardo [4 ]
Garrigos, Laia [3 ]
Garcia-Giralt, Natalia [1 ]
Diez-Perez, Adolfo [5 ]
Tusquets, Ignacio [3 ]
Nogues, Xavier [6 ]
机构：
[1] IMIM, Madrid, Spain
[2] Univ Oxford, Oxford OX1 2JD, England
[3] Parc Salut Mar, Dept Med Oncol, Barcelona, Spain
[4] Inst Salud Carlos III FEDER, URFOA IMIM, Red Temat Invest Cooperat Envejecimiento & Fragil, Barcelona, Spain
[5] Autonomous Univ Barcelona, E-08193 Barcelona, Spain
[6] Inst Municipal Invest Med, Madrid, Spain
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU0434
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Relation of genes in estrogen and vitamin D signaling to bone mineral density loss in aromatase inhibitors treatment
    Servitja, Sonia
    Rodriguez-Sanz, Maria
    Garcia-Giralt, Natalia
    Torres, Elisabet
    Prieto-Alhambra, Dani
    Mellibovsky, Leonardo
    Tusquets, Ignacio
    Diez-Perez, Adolf
    Nogues, Xavi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] ONE YEAR AROMATASE INHIBITORS TREATMENT EFFECT ON BONE MINERAL DENSITY: IS IT SIGNIFICANT?
    Barbu, C. G.
    Mocanu, D.
    Fica, S.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S358 - S358
  • [3] IMPACT OF CHEMOTHERAPY ON BONE MINERAL DENSITY IN POSTMENOPATHIC WOMEN WITH BREAST CANCER IN TREATMENT WITH AROMATASE INHIBITORS
    Loarce-Martos, J.
    Sifuentes Giraldo, W. A.
    Maldonado Romero, L. V.
    Ahijon Lana, M.
    Velazquez Arce, C.
    Martinez Janez, N.
    Vazquez Diaz, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 698 - 698
  • [4] Bone loss and the aromatase inhibitors
    J Lester
    R Coleman
    British Journal of Cancer, 2005, 93 : S16 - S22
  • [5] Aromatase inhibitors and bone loss
    Lipton, Allan
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1039 - +
  • [6] Bone loss and the aromatase inhibitors
    Lester, J
    Coleman, R
    BRITISH JOURNAL OF CANCER, 2005, 93 (Suppl 1) : S16 - S22
  • [7] BONE MINERAL DENSITY IN PATIENTS WITH AROMATASE INHIBITORS COMPARED TO POSTMENOPAUSAL OSTEOPOROSIS
    Oncu, J.
    Kuran, B.
    Sen, N.
    Yilmaz, F.
    Ercalik, C.
    Dogu, B.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S476 - S477
  • [8] Bone mineral density in women with breast cancer and the impact of aromatase inhibitors
    Saleh, B.
    Gronland, N.
    Singer, J.
    Bradpiece, H.
    Patel, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 384 - 385
  • [9] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Khachidze, N.
    Giorgadze, E.
    Tsagareli, M.
    Dolidze, N.
    Sharikadze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S237 - S238
  • [10] Is there overlap between the genetic determinants of mammographic density and bone mineral density?
    Dite, GS
    Wark, JD
    Giles, GG
    English, DR
    McCredie, MRE
    Hopper, JL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (09) : 2266 - 2268
12345